Compumedics Ltd (AU:CMP) — Market Cap & Net Worth
Market Cap & Net Worth: Compumedics Ltd (CMP)
Compumedics Ltd (AU:CMP) has a market capitalization of $39.86 Million (AU$56.33 Million) as of May 3, 2026. Listed on the AU stock exchange, this Australia-based company holds position #22702 globally and #862 in its home market, demonstrating a -4.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Compumedics Ltd's stock price AU$0.28 by its total outstanding shares 199761754 (199.76 Million). Analyse CMP operating cash flow to see how efficiently the company converts income to cash.
Compumedics Ltd Market Cap History: 2015 to 2026
Compumedics Ltd's market capitalization history from 2015 to 2026. Data shows change from $55.83 Million to $39.86 Million (-2.03% CAGR).
Compumedics Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Compumedics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.93x
Compumedics Ltd's market cap is 0.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $122.97 Million | $37.54 Million | $3.27 Million | 3.28x | 37.57x |
| 2017 | $59.36 Million | $34.42 Million | $1.30 Million | 1.72x | 45.49x |
| 2018 | $56.54 Million | $37.00 Million | $2.78 Million | 1.53x | 20.31x |
| 2019 | $113.08 Million | $41.51 Million | $4.02 Million | 2.72x | 28.16x |
| 2020 | $70.67 Million | $35.07 Million | -$5.84 Million | 2.02x | N/A |
| 2021 | $52.30 Million | $35.74 Million | $998.00K | 1.46x | 52.40x |
| 2022 | $28.27 Million | $37.76 Million | $1.36 Million | 0.75x | 20.83x |
| 2023 | $39.58 Million | $42.41 Million | -$6.12 Million | 0.93x | N/A |
| 2024 | $37.46 Million | $49.72 Million | -$338.00K | 0.75x | N/A |
| 2025 | $47.35 Million | $51.04 Million | -$1.27 Million | 0.93x | N/A |
Competitor Companies of CMP by Market Capitalization
Companies near Compumedics Ltd in the global market cap rankings as of May 3, 2026.
Key companies related to Compumedics Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Compumedics Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Compumedics Ltd's market cap moved from $55.83 Million to $ 39.86 Million, with a yearly change of -2.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$39.86 Million | -15.82% |
| 2025 | AU$47.35 Million | +26.42% |
| 2024 | AU$37.46 Million | -5.36% |
| 2023 | AU$39.58 Million | +40.00% |
| 2022 | AU$28.27 Million | -45.95% |
| 2021 | AU$52.30 Million | -26.00% |
| 2020 | AU$70.67 Million | -37.50% |
| 2019 | AU$113.08 Million | +100.00% |
| 2018 | AU$56.54 Million | -4.76% |
| 2017 | AU$59.36 Million | -51.72% |
| 2016 | AU$122.97 Million | +120.25% |
| 2015 | AU$55.83 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Compumedics Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.86 Million USD |
| MoneyControl | $39.86 Million USD |
| MarketWatch | $39.86 Million USD |
| marketcap.company | $39.86 Million USD |
| Reuters | $39.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Compumedics Ltd
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST… Read more